| AMINO ACID FORMULA WITH FAT, CARBOHYDRATE, VITAMINS, MINERALS, TRACE ELEMENTS AND
MEDIUM CHAIN TRIGLYCERIDES |
Essential Care Jr® |
Cortex Health Pty Ltd |
Multiple food allergies and various gastrointestinal disorders and allergic conditions |
Mar 2021 |
Recommended |
| GUSELKUMAB |
Tremfya® |
Janssen-Cilag Pty Ltd |
Severe Chronic Plaque Psoriasis (CPP) |
Mar 2021 |
Not Recommended |
| ATEZOLIZUMAB |
Tecentriq® |
Roche Products Pty Ltd |
Breast cancer |
Mar 2021 |
Not Recommended |
| BEVACIZUMAB |
Mvasi® |
Amgen Australia Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Mar 2021 |
Recommended |
| USTEKINUMAB |
Stelara® |
Janssen-Cilag Pty Ltd |
Plaque psoriasis |
Mar 2021 |
Recommended |
| BUDESONIDE |
Jorveza® |
Dr Falk Pharma Australia Pty Ltd |
Eosinophilic Oesophagitis (EoE) |
Mar 2021 |
Not Recommended |
| CABOTEGRAVIR/CABOTEGRAVIR AND RILPIVIRINE |
Cabenuva® |
Viiv Healthcare Pty Ltd |
Human Immunodeficiency virus (HIV) |
Mar 2021 |
Not Recommended |
| NIRAPARIB |
Zejula® |
GlaxoSmithKline Australia Pty Ltd |
Ovarian, fallopian tube, or primary peritoneal cancer |
Mar 2021 |
Not Recommended |
| EVOLOCUMAB |
Repatha® |
Amgen Australia Pty Limited |
Familial heterozygous hypercholesterolaemia; Non-familial hypercholesterolaemia; Familial
homozygous hypercholesterolaemia |
Mar 2021 |
Recommended |
| TUCATINIB |
Tukysa® |
Lucid Health Consulting Pty Ltd |
Breast cancer |
Mar 2021 |
Not Recommended |
| LACOSAMIDE |
Vimpat® |
UCB Australia Proprietary Ltd |
Epilepsy |
Mar 2021 |
Recommended |
| UPADACITINIB |
Rinvoq® |
Abbvie Pty Ltd |
Psoriatic arthritis |
Mar 2021 |
Recommended |
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Colorectal cancer |
Mar 2021 |
Recommended |
| DAROLUTAMIDE |
Nubeqa® |
Bayer Australia Ltd |
Prostate cancer |
Mar 2021 |
Not Recommended |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR |
Trikafta® |
Vertex Pharmaceuticals (Australia) Pty Ltd |
Cystic fibrosis |
Mar 2021 |
Deferred |
| GLATIRAMER ACETATE |
Glatira® |
Juno Pharmaceuticals Pty Ltd |
Multiple sclerosis |
Mar 2021 |
Recommended |
| HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND
CARBOHYDRATE |
- KetoCal 3:1®
- KetoCal 4:1®
|
Nutricia Australia Pty Ltd |
Ketogenic Diet |
Mar 2021 |
Recommended |
| ROXADUSTAT |
Evrenzo® |
Astrazeneca Pty Ltd |
Anaemia associated with chronic kidney disease |
Mar 2021 |
Not Applicable |
| ABEMACICLIB |
Verzenio® |
Eli Lilly Australia Pty Ltd |
Breast cancer |
Mar 2021 |
Recommended |
| TEDUGLUTIDE |
Revestive® |
Takeda Pharmaceuticals Australia Pty Ltd |
Short bowel syndrome (SBS) |
Mar 2021 |
Recommended |
| TETRACOSACTIDE |
Synacthen® |
Clinect Pty Ltd |
Hypsarrhythmia and/or infantile spasms |
Mar 2021 |
Deferred |
| ENCORAFENIB |
Braftovi® |
Pierre Fabre Australia Pty Ltd |
Colorectal cancer |
Mar 2021 |
Deferred |
| FILGOTINIB |
Jyseleca® |
Gilead Sciences Pty Ltd |
Rheumatoid arthritis |
Mar 2021 |
Not Applicable |
| DECITABINE + CEDAZURIDINE |
Inqovi® |
Otsuka Australia Pharmaceutical Pty Ltd |
Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML) |
Mar 2021 |
Not Recommended |
| NIVOLUMAB AND IPILIMUMAB |
Opdivo®, Yervoy® |
Bristol-Myers Squibb Australia Pty Ltd |
Malignant pleural mesothelioma |
Mar 2021 |
Recommended |
| TESTOSTERONE |
AndroForte 5® |
Lawley Pharmaceuticals Pty Ltd |
Testosterone deficiency |
Mar 2021 |
Recommended |
| UPADACITINIB |
Rinvoq® |
Abbvie Pty Ltd |
Ankylosing spondylitis |
Mar 2021 |
Recommended |
| NINTEDANIB |
Ofev® |
Boehringer Ingelheim Pty Ltd |
Progressive fibrosing interstitial lung disease (PF-ILD) |
Mar 2021 |
Not Recommended |
| VENETOCLAX |
Venclexta® |
Abbvie Pty Ltd |
Acute myeloid leukaemia (AML) |
Mar 2021 |
Not Recommended |
| BROLUCIZUMAB |
Beovu® |
Novartis Pharmaceuticals Australia Pty Limited |
Wet age-related macular degeneration (AMD) |
Mar 2021 |
Recommended |
| OFATUMUMAB |
Kesimpta® |
Novartis Pharmaceuticals Australia Pty Ltd |
Multiple sclerosis (MS) |
Mar 2021 |
Recommended |
| TERIPARATIDE |
Terrosa® |
Gedeon Richter Australia Pty Ltd |
Severe established osteoporosis |
Mar 2021 |
Recommended |
| CABAZITAXEL |
Cabazitaxel Ever Pharma® |
Interpharma Pty Ltd |
Prostate cancer |
Mar 2021 |
Recommended |
| AVELUMAB |
Bavencio® |
Merck Healthcare Pty Ltd |
Urothelial carcinoma |
Mar 2021 |
Recommended |
| RIPRETINIB |
Qinlock® |
Specialised Therapeutics PM Pty Ltd |
Gastrointestinal stromal tumour |
Mar 2021 |
Not Recommended |
| SEMAGLUTIDE |
Ozempic® |
Novo Nordisk Pharmaceuticals Pty. Ltd |
Type 2 diabetes mellitus (T2DM) |
Mar 2021 |
Recommended |
| MELATONIN |
Slenyto® |
Aspen Pharmacare Australia Pty Ltd |
Insomnia |
Mar 2021 |
Not Recommended |
| NIVOLUMAB |
Opdivo® |
Bristol-Myers Squibb Australia Pty Ltd |
Non-small cell lung cancer (NSCLC) |
Mar 2021 |
Not Recommended |
| BRENTUXIMAB VEDOTIN |
Adcetris® |
Takeda Pharmaceuticals Australia Pty Ltd |
T-cell lymphoma |
Mar 2021 |
Recommended |
| BUROSUMAB |
Crysvita® |
Kyowa Kirin Australia Pty Ltd |
X-linked hypophosphataemia |
Mar 2021 |
Not Recommended |
| ACICLOVIR |
Xorox® |
Clinect Pty Ltd |
Herpes simplex keratitis |
Mar 2021 |
Not Recommended |
| TAFAMIDIS |
Vyndamax® |
Pfizer Australia Pty Ltd |
Transthyretin cardiac amyloidosis |
Mar 2021 |
Not Recommended |
| RISDIPLAM |
Evrysdi® |
Roche Products Pty Ltd |
Spinal muscular atrophy |
Mar 2021 |
Recommended |
| DEUTETRABENAZINE |
Austedo® |
Teva Pharma Australia Pty Ltd |
Chorea associated with Huntington's disease |
Mar 2021 |
Not Recommended |
| OLAPARIB |
Lynparza® |
AstraZeneca Pty Ltd |
Prostate cancer |
Mar 2021 |
Not Recommended |
| AVELUMAB |
Bavencio® |
Merck Healthcare Pty Ltd |
Renal cell carcinoma (RCC) |
Mar 2021 |
Recommended |
| HIGH FAT FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND
CARBOHYDRATE |
K.Yo® |
Vitaflo Australia Pty Ltd |
Dietary management of conditions requiring a ketogenic diet |
Mar 2021 |
Recommended |
| CICLOSPORIN |
Ikervis® |
Seqirus (Australia) Pty Ltd |
Dry eye disease in patients with keratitis |
Mar 2021 |
Recommended |
| ESLICARBAZEPINE |
Zebinix® |
Stada Pharmaceuticals Australia Pty Ltd |
Epilepsy |
Mar 2021 |
Not Recommended |
| GEMTUZUMAB OZOGAMICIN |
Mylotarg® |
Pfizer Australia Pty Ltd |
Acute myeloid leukaemia (AML) |
Mar 2021 |
Not Recommended |
| OBETICHOLIC ACID |
Ocaliva® |
Chiesi Australia Pty Ltd |
Primary biliary cholangitis (PBC) |
Mar 2021 |
Recommended |
| ENZALUTAMIDE |
Xtandi® |
Astellas Pharma Australia Pty Ltd |
Metastatic prostate cancer |
Mar 2021 |
Recommended |
| ABIRATERONE ACETATE |
Zytiga® |
Janssen-Cilag Pty Ltd |
Metastatic prostate cancer |
Mar 2021 |
Recommended |